Gregg Talbert

Gregg Talbert is a seasoned executive with extensive experience in the pharmaceutical industry, currently serving as Senior Vice President at Roche, where responsibilities include overseeing Pharma transactions and leading efforts in Personalized Health Care and digital partnering since January 2015. Talbert has a strong background in business development, having previously held senior positions at Eli Lilly and Company from 1996 to 2014, including Senior Director of Diabetes Strategy and Business Development and Global Exenatide Transition Leader. Talbert holds a Ph.D. in Decision Sciences and an MBA from Duke University, along with a BS in Electrical Engineering from Cornell University, and has demonstrated expertise in strategic partnering, M&A transactions, and the integration of innovative healthcare solutions across various therapeutic areas.